Intaglob 16.5% Injection is a medication used to boost the body's natural immune system in individuals with weakened immune systems, reducing the risk of infections. This injection is derived from healthy human blood containing specialized defensive substances called antibodies, which play a crucial role in fighting off infections.

Primarily, Intaglob 16.5% Injection is effective in preventing infections in individuals over 20 years old who have undergone bone marrow transplants within the initial 100 days post-transplant. It is particularly useful for patients with severely impaired antibody-forming capacity, increasing their ability to combat infections. The therapy provides antibodies that the body may not be producing adequately, benefiting both children and adults. The administration of Intaglob 16.5% Injection is through injection, with doctors monitoring patients for potential side effects post-administration.

While generally safe, Intaglob 16.5% Injection may cause side effects like injection site reactions such as swelling, redness, pain, itching, bruising, rash, and flushing. Patients are advised to promptly inform their doctor if they experience any side effects or feel unwell, as there may be ways to manage these effects. Notably, individuals with blood clotting problems or recent or planned vaccinations should inform their healthcare provider before using this medication. Additionally, its safety during pregnancy and breastfeeding is uncertain, necessitating consultation with a doctor prior to administration.

Intaglob 16.5% Injection belongs to the immunising agents class of medications and is utilized in treating immunoglobulin deficiencies and certain inflammatory conditions. It is beneficial for individuals with primary immunodeficiency present from birth or secondary immunodeficiency developed later in life. Furthermore, this injection is useful in managing inflammatory disorders including immune thrombocytopenia, Guillain-Barre syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

Containing 'Human normal immunoglobulin,' Intaglob Injection 2 ml functions by replacing deficient antibodies crucial for combating infections and inflammation, resembling the body's natural immunoglobulins. Immunoglobulins are vital components of the immune system responsible for identifying and destroying foreign substances within the body, aiding in reducing inflammation and enhancing immunity. Administered by trained healthcare professionals, this injection may lead to mild and temporary side effects such as swelling at the injection site, headache, body pain, fever, flu-like symptoms, and throat irritation.

Individuals allergic to any components of Intaglob Injection 2 ml or with blood clotting disorders should avoid its use. It is essential to disclose recent vaccinations or previous use of the product to the healthcare provider before administration. Caution is advised in individuals with immunoglobulin A deficiency and the elderly population. While probably safe for children, pregnant or breastfeeding women, and potentially interacting with alcohol, Intaglob Injection 2 ml may cause dizziness, necessitating avoidance of driving or operating heavy machinery while experiencing such symptoms.